Hyperfine, Inc. (HYPR)
1.49
+0.08
(+5.67%)
USD |
NASDAQ |
May 20, 16:00
1.49
0.00 (0.00%)
After-Hours: 20:00
Hyperfine EPS Diluted (Quarterly) : -0.0883 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| IRadimed Corp. | 0.4521 |
| Treace Medical Concepts, Inc. | -0.2781 |
| CVRx, Inc. | -0.4978 |
| Lucid Diagnostics, Inc. | -0.1686 |
| Abbott Laboratories | 0.6165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.623M |
| Revenue (Quarterly) | 3.903M |
| Total Expenses (Quarterly) | 12.53M |
| Enterprise Value | 112.06M |
| Gross Profit Margin (Quarterly) | 50.70% |
| Profit Margin (Quarterly) | -220.9% |
| Earnings Yield | -27.43% |
| Normalized Earnings Yield | -26.70 |